Improvement of Intranasal Drug Delivery with Intravail® Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System-Reference-Cited by-同舟云学术

Improvement of Intranasal Drug Delivery with Intravail® Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System

Published:2021-08-25 Issue:4 Volume:21 Page:361-369
ISSN:1174-5886
Container-title:Drugs in R&D
language:en
Short-container-title:Drugs R D

Author:

Rabinowicz Adrian L.^ORCID,Carrazana Enrique^ORCID,Maggio Edward T.^ORCID

Funder

Neurelis, Inc.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40268-021-00360-5.pdf

Reference50 articles.

1. Djupesland PG. Nasal drug delivery devices: characteristics and performance in a clinical perspective: a review. Drug Deliv Transl Res. 2013;3(1):42–62.

2. Fromer LM, Ortiz GR, Dowdee AM. Assessment of patient attitudes about mometasone furoate nasal spray: the ease-of-use patient survey. World Allergy Organ J. 2008;1(9):156–9.

3. Bitter C, Suter-Zimmermann K, Surber C. Nasal drug delivery in humans. Curr Probl Dermatol. 2011;40:20–35.

4. Costantino HR, et al. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm. 2007;337(1–2):1–24.

5. Leonard AK, et al. In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo. Int J Pharm. 2007;335(1–2):138–46.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of neffy, an Epinephrine Nasal Spray, for Severe Allergic Reactions;Pharmaceutics;2024-06-14

2. Validation of the Absorption-Enhancing Ability of Oligoarginines Grafted onto a Backbone of Hyaluronic Acid through Animal Studies from Rodents to Primates;Molecular Pharmaceutics;2024-05-28

3. Benzodiazepines for the Treatment of Seizure Clusters;CNS Drugs;2024-02

4. Role of inflammation, angiogenesis and oxidative stress in developing epilepsy;Targeting Angiogenesis, Inflammation, and Oxidative Stress in Chronic Diseases;2024

5. Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs;Pharmaceutics;2023-12-28